N. Kim

发表

The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3.

Sang Gyun Kim, Y. Bang, Jung-Hyun Park, 2005, Molecular biology of the cell.

Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies

Tae-You Kim, Jae-Yong Chung, Noe Kyeong Kim, 2004, Clinical Cancer Research.

Transforming Growth Factor-β1 Induces Apoptosis through Fas Ligand-independent Activation of the Fas Death Pathway in Human Gastric SNU-620 Carcinoma Cells

Sang Gyun Kim, Jung Weon Lee, Y. Bang, 2003 .

Genetic integrity of transforming growth factor β (TGF‐β) receptors in cervical carcinoma cell lines: loss of growth sensitivity but conserved transcriptional response to TGF‐β

Y. Song, Y. Bang, Seong-Jin Kim, 1998 .

Efficacy of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer.

Y. Bang, Dong-Wan Kim, D. Heo, 2005, Oncology reports.

Infections in Acute Leukemia: A Retrospective Study of 148 Patients

B. Kim, Myung-Shik Lee, M. Oh, 1986, The Korean journal of internal medicine.

Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer.

I. Choi, M. Kook, Young-Woo Kim, 2009, Pharmacogenomics.

Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.

Y. Bang, Jae-Won Park, Y. Im, 2002, Biochemical and biophysical research communications.

Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea.

B. Kim, Sung-Soo Yoon, J. Ha, 2009, Thrombosis research.

Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy.

Y. Bang, Dong-Wan Kim, D. Heo, 2004, Japanese journal of clinical oncology.

Multicentric Castleman’s disease complicated by tumor lysis syndrome

Keun-Wook Lee, B. Kim, Sung-Soo Yoon, 2004, Annals of Hematology.

Predictive factors for the efficacy of cetuximab plus chemotherapy as salvage therapy in metastatic gastric cancer patients

I. Choi, Soo-Jeong Cho, M. Kook, 2010, Cancer Chemotherapy and Pharmacology.

CYP2A6 genetic polymorphism as a predictive marker for clinical outcomes in patients (pts) with metastastic gastric carcinoma (MGC) treated with S-1 plus docetaxel

Hoon-Kyo Kim, Hyeong-Seok Lim, Sook Ryun Park, 2007 .

Clinical Characteristics and Treatment Outcomes

Dong-Wan Kim, D. Heo, B. Kim, 1999 .

Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement

Young-Woo Kim, K. Ryu, J. Lee, 2010, Cancer Chemotherapy and Pharmacology.

Primary Systemic Anaplastic Large Cell Lymphoma in a Single Korean Institution: Clinical Characteristics and Treatment Outcome

Y. Bang, Dong-Wan Kim, D. Heo, 2006, Journal of Korean medical science.

Phase II Clinical Trial of Genexol R ( Paclitaxel ) and Cisplatin for Patients with N on-Sm all Cell Lung Cancer

Keunchil Park, Y. Bang, Sang-We Kim, 2003 .

Colorectal Cancer in Korea: Characteristics and Trends

Y. Bang, Dong-Wan Kim, D. Heo, 2002, Tumori.

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib.

Young Tae Kim, Doo Hyun Chung, Tae-You Kim, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation

Y. Bang, Dong-Wan Kim, D. Heo, 2006, Clinical Cancer Research.

Hepatitis B Virus Infection and B‐Cell Non‐Hodgkin's Lymphoma in a Hepatitis B Endemic Area: A Case‐control Study

Y. Bang, D. Heo, C. Kim, 2002, Japanese journal of cancer research : Gann.

Therapeutic Outcome of Extranodal NK/T-Cell Lymphoma Initially Treated with Chemotherapy Result of Chemotherapy in NK/T-Cell Lymphoma

Ji Yeun Kim, Y. Bang, D. Heo, 2003, Acta oncologica.

Endobronchial Metastasis of Malignant Melanoma, Diagnosed by Bronchoscopy

Y. Bang, S. Han, N. Kim, 1988, The Korean journal of internal medicine.

p130 mediates TGF-β-induced cell-cycle arrest in Rb mutant HT-3 cells

Y. Bang, Tae-You Kim, H. Jong, 2002 .

Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-β1-induced apoptosis in human gastric cancer cells

Sang Gyun Kim, Y. Bang, Seong-Jin Kim, 2001, Oncogene.

Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells

Jung Weon Lee, Y. Bang, M. Jung, 2003, Oncogene.

A Phase II Study of Genexol® ( paclitaxel ) in Metastatic Breast Cancer

Y. Bang, J. S. Kim, Kihyun Kim, 2001 .

Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type.

K. Chang, Yeon-Hee Park, Y. Bang, 2005, Blood.

Tumor lysis syndrome after capecitabine plus cisplatin treatment in advanced gastric cancer.

I. Choi, Soo-Jeong Cho, M. Kook, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Docetaxel 75 mg/m(2) is active and well tolerated in patients with metastatic or recurrent gastric cancer: a phase II trial.

Y. Bang, Yoon-Koo Kang, D. Heo, 2002, Japanese journal of clinical oncology.

Phase II study of low-dose paclitaxel and cisplatin as second-line therapy in 5-fluorouracil and platinum pretreated gastric cancer

D. Heo, S. Im, Keun-Wook Lee, 2005 .

Influence of exposure and infusion times on the cytotoxicity and pharmacokinetics of cis - malonato[(4R, 5R )-4,5-bis(aminomethyl)- 2-isopropyl-1,3-dioxolane]platinum(II)

Y. Bang, D. Heo, Hun-Taek Kim, 1997, Cancer Chemotherapy and Pharmacology.

Docetaxel + 5-fluorouracil + cisplatin 3-day combination chemotherapy as a first-line treatment in patients with unresectable gastric cancer.

Y. Bang, Dong-Wan Kim, D. Heo, 2005, Japanese journal of clinical oncology.

Enhancement of adenoviral transduction with polycationic liposomes in vivo

D. Heo, Y. Yeom, M. Sung, 2000, Cancer Gene Therapy.

Synergistic anti‐tumor effects with co‐expression of GM‐CSF and IFN‐γ in murine tumors

D. Heo, M. Sung, Sang-Goo Lee, 1998 .

Adult patients with t(8;21) acute myeloid leukemia had no superior treatment outcome to those without t(8;21): a single institution’s experience

Keun-Wook Lee, B. Kim, D. S. Lee, 2004, Annals of Hematology.

Prognostic Factors of Patients with Thymoma

J. Ahn, Y. Bang, D. Heo, 1996, The Korean journal of internal medicine.

A multi-center, late phase II clinical trial of Genexol (paclitaxel) and cisplatin for patients with advanced gastric cancer.

Y. Bang, Dong-Wan Kim, D. Heo, 2004, Oncology reports.

Genetic changes in the transforming growth factor f8 (TGF-fi) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-,

Kim, M. Sporn, A. Roberts, 2022 .

The Role of Sex Steroid Hormones in Female Sexual Function and Dysfunction

I. Goldstein, A. Traish, N. Kim, 2004, Clinical obstetrics and gynecology.

Cytotoxic effects of pemetrexed in gastric cancer cells

Y. Bang, S. Im, K. Jung, 2005, Cancer science.

Multiple Myeloma in Korea*

Hyo Jin Kim, Y. Bang, D. Heo, 1987, The Korean journal of internal medicine.

Methylation of specific CpG sites in the promoter region could significantly down‐regulate p16INK4a expression in gastric adenocarcinoma

Y. Bang, W. Kim, H. Jong, 2000, International journal of cancer.

Artificial nutrition and hydration in terminal cancer patients: the real and the ideal

Y. Bang, D. Heo, S. Im, 2007, Supportive Care in Cancer.

Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone.

Y. Bang, Dong-Wan Kim, D. Heo, 2003, Japanese journal of clinical oncology.

Natural killer cell activity depression in peripheral blood and ascites from gastric cancer patients with high TGF-β1 expression

Y. Bang, D. Heo, George P. Kim, 1998 .

Alterations of p16INK4A and p15INK4B genes in gastric carcinomas

Y. Bang, K. Choe, K. Lee, 1997, Cancer.

Transcriptional inactivation of the tissue inhibitor of metalloproteinase‐3 gene by dna hypermethylation of the 5'‐CpG island in human gastric cancer cell lines

Sang Gyun Kim, Y. Bang, H. Jong, 2000, International journal of cancer.

Transcriptional repression of the transforming growth factor-β type I receptor gene by DNA methylation results in the development of TGF-β resistance in human gastric cancer

Y. Bang, Y. Im, Seong-Jin Kim, 1999, Oncogene.

Gastric epithelial reactive oxygen species prevent normoxic degradation of hypoxia-inducible factor-1alpha in gastric cancer cells.

H. Jung, Y. Bang, Tae-You Kim, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Aberrant methylation of integrin α4 gene in human gastric cancer cells

Jung Weon Lee, Y. Bang, W. Kim, 2004, Oncogene.

AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity

Tae-You Kim, Noe Kyeong Kim, Jung Weon Lee, 2004, Oncogene.

A phase III randomized study of 5‐fluorouracil and cisplatin versus 5‐fluorouracil, doxorubicin, and mitomycin C versus 5‐fluorouracil alone in the treatment of advanced gastric cancer

D. Shin, Y. Bang, Yoon-Koo Kang, 1993, Cancer.

A multivariate analysis of prognostic factors in colorectal cancer

Y. Bang, Dong-Wan Kim, D. Heo, 2003 .

Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa®, ZD1839) in chemotherapy‐resistant non‐small cell lung cancer

Y. Bang, Dong-Wan Kim, D. Heo, 2005, International journal of cancer.

Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma

Y. Bang, Y. Jo, Dong-Wan Kim, 2004, Cancer.

Paclitaxel/Platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer.

Y. Bang, Sang-Il Kim, Dong-Wan Kim, 2005, Japanese journal of clinical oncology.

A Phase III Randomized Trial of Combined Chemoradiotherapy Versus Radiotherapy Alone in Locally Advanced Non–Small-Cell Lung Cancer

Y. Bang, D. Heo, Tae-You Kim, 2002, American journal of clinical oncology.

The treatment of severe aplastic anemia: outcomes of bone marrow transplantation and immunosuppressive therapy in a single institution of Korea.

B. Kim, Sung-Soo Yoon, Inho Kim, 2003, Journal of Korean medical science.

Assessment of Immature Reticulocyte Fraction as an Early Predictor of Marrow Engraftment After Hematopoiectic Stem Cell Transplantation

Mingoo Kim, B. Chun, N. Kim, 2011 .

Ontogeny of natural killer cells and T cells by analysis of BCR-ABL rearrangement from patients with chronic myelogenous leukaemia.

E. Cho, D. Heo, B. Kim, 2000 .

Class I Histone Deacetylase-Selective Novel Synthetic Inhibitors Potently Inhibit Human Tumor Proliferation

Sang Gyun Kim, Jung Weon Lee, Y. Bang, 2004, Clinical Cancer Research.

Phase II Study of Low-dose Paclitaxel and Cisplatin as a Second-line Therapy after 5-Fluorouracil/Platinum Chemotherapy in Gastric Cancer

Y. Bang, Dong-Wan Kim, D. Heo, 2007, Journal of Korean medical science.

Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer.

Y. Bang, Dong-Wan Kim, D. Heo, 2005, Japanese journal of clinical oncology.

A Multi-Center, Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Cisplatin for Patients with Non-Small Cell Lung Cancer.

Keunchil Park, Y. Bang, Y. Im, 2003, Cancer research and treatment : official journal of Korean Cancer Association.

Metastasis-Associated Protein S100A4 and p53 Predict Relapse in Curatively Resected Stage III and IV (M0) Gastric Cancer

Y. Bang, Dong-Wan Kim, D. Heo, 2008, Cancer investigation.

Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5‐fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma

D. Noh, Y. Bang, H. Chang, 2000, Cancer.

A Pilot Study of Bortezomib in Korean Patients with Relapsed or Refractory Myeloma

Keun-Wook Lee, Seung Tae Lee, B. Kim, 2005, Journal of Korean medical science.

Evaluation of Bone Metastases by Tc‐99m MDP Imaging in Patients With Stomach Cancer

D. Lee, M. Lee, June-Key Chung, 1995, Clinical nuclear medicine.

Herpes simplex virus thymidine kinase and granulocyte macrophage colony-stimulating factor combination gene therapy in a murine CT26 cell colon cancer model

D. Heo, K. Lee, N. Kim, 2004, Cancer Gene Therapy.

First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy ± radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma

Y. Bang, Dong-Wan Kim, D. Heo, 2006, Leukemia & lymphoma.

Chylothorax in Gorham's disease.

Y. Bang, D. Heo, Inho Kim, 2002, Journal of Korean medical science.

O pen-label, Random ized C om parison of the E fficacy of Intra- venous Dolasetron M esy late and O ndansetron in the Prevention of A cute and Delayed C isplatin-induced Em esis in C ancer Patients

Y. Bang, Sang-Il Kim, Dong-Wan Kim, 2010 .

Open-label, randomized comparison of the efficacy of intravenous dolasetron mesylate and ondansetron in the prevention of acute and delayed cisplatin-induced emesis in cancer patients.

Y. Bang, Sang-Il Kim, Dong-Wan Kim, 2004, Cancer research and treatment : official journal of Korean Cancer Association.

Ontogeny of natural killer cells and T cells by analysis of BCR–ABL rearrangement from patients with chronic myelogenous leukaemia

E. Cho, D. Heo, Y. Y. Lee, 2000, British journal of haematology.

Clinical Features of Waldenstrom Macroglobulinemia in Korea

S. Park, E. Cho, D. Shin, 2004, The Korean journal of internal medicine.

Angioimmunoblastic T-cell Lymphoma: Clinical Characteristics and Treatment Outcomes

Sang-Il Kim, Dong-Wan Kim, D. Heo, 2005 .

A combination of HER‐2 status and the St. Gallen classification provides useful information on prognosis in lymph node‐negative breast carcinoma

W. Han, D. Noh, Y. Bang, 2004, Cancer.

CPR or DNR? End-of-life decision in Korean cancer patients: a single center’s experience

Y. Bang, Dong-Wan Kim, D. Heo, 2006, Supportive Care in Cancer.

Predict Relapse in Curatively Resected Stage III and IV ( M 0 ) Gastric Cancer

Y. Bang, Dong-Wan Kim, D. Heo, 2008 .

Extramedullary Relapse Confirmed by Fluorescence In Situ Hybridization Study of an Ear Mass in Acute Promyelocytic Leukemia

Keun-Wook Lee, S. Park, B. Kim, 2004, International journal of hematology.

Neoadjuvant Chemotherapy Followed by Radiotherapy in Epidermoid Carcinoma of Anus

Y. Bang, D. Heo, Hong-Gyun Wu, 2004, Tumori.

Reduced Dose Intensity FOLFOX-4 as First Line Palliative Chemotherapy in Elderly Patients with Advanced Colorectal Cancer

Y. Bang, Dong-Wan Kim, D. Heo, 2005, Journal of Korean medical science.

Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells.

Sang Gyun Kim, Y. Bang, S. Im, 2006, Anticancer research.

Clinical Outcomes and Prognostic Factors of Metastatic Gastric Carcinoma Patients Who Experience Gastrointestinal Perforation During Palliative Chemotherapy

Young-Woo Kim, K. Ryu, Sook Ryun Park, 2010, Annals of Surgical Oncology.

A Phase I study of cis‐malonato[(4R,5R)‐4,5‐bis(aminomethyl)‐1,3‐dioxolane] platinum(II) in patients with advanced malignancies

Y. Bang, D. Heo, Tae-You Kim, 2001, Cancer.

Phase II clinical trial of SKI‐2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma

J. Ahn, E. Cho, Y. Bang, 1999, Cancer.

Aberrant methylation of integrin alpha4 gene in human gastric cancer cells.

Jung Weon Lee, Y. Bang, W. Kim, 2004, Oncogene.

A Spindle Cell Tumor of Unknown Origin and Diffuse Bone Marrow Involvement in a Patient with Hypercalcemia

J. Yim, D. Heo, G. Kang, 1999, Tumori.

Efficacy of modified regimen with attenuated doses of paclitaxel plus carboplatin combination chemotherapy in elderly and/or weak patients with advanced non-small cell lung cancer.

Y. Bang, D. Heo, D. Y. Kim, 2003, Lung cancer.

Antibiotic use during the last days of life in cancer patients.

Y. Bang, J. Kim, Dong-Wan Kim, 2006, European journal of cancer care.

Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta.

M. Sporn, A. Roberts, Y. Bang, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Prognostic factors of Krukenberg's tumor.

Y. Bang, D. Heo, H. Kim, 2001, Gynecologic oncology.

Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions.

O. Kim, S. Kim, N. Kim, 2003, Thrombosis research.

Phase II study of a triplet regimen of S-1 combined with irinotecan and oxaliplatin in patients with metastatic gastric cancer: clinical and pharmacogenetic results.

Soo-Jeong Cho, Young-Woo Kim, Je-Keun Rhee, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Locoregional response and increased natural killer activity after intratumoral injection of HLA-B7/beta2-microglobulin gene in patients with cancer.

E. Cho, Y. Bang, D. Heo, 1998, Human gene therapy.

Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone.

Y. Bang, D. Heo, S. Im, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer.

Y. Bang, J. Kim, D. Heo, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Transforming growth factor-beta 1 induces apoptosis through Fas ligand-independent activation of the Fas death pathway in human gastric SNU-620 carcinoma cells.

Y. Bang, Tae-You Kim, H. Jong, 2004, Molecular biology of the cell.

Biomarker analysis in stage III–IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival

S. Im, K. Lee, N. Kim, 2009, British Journal of Cancer.